Regulatory T-Cell Therapy for Graft-versus-host Disease

Overview

Journal J Immunol Res Ther

Date 2016 Oct 11

PMID 27722210

Citations 24

Authors

Jessica Heinrichs

David Bastian

Anandharaman Veerapathran

Claudio Anasetti

Brain Betts

Xue-Zhong Yu

Affiliations

Soon will be listed here.

Abstract

Graft-versus-host disease (GVHD) is a significant cause of non-relapse mortality after allogeneic hematopoietic cell transplantation (allo-HCT). Existing strategies to prevent and treat GVHD are incomplete, where a significant portion of allo-HCT recipients developed this complication. Despite this, one such therapy has emerged involving the use of regulatory T cells (Tregs) to control GVHD. The use of natural Tregs (nTregs) yielded positive pre-clinical results and are actively under investigation to reduce GVHD. However, broad application of this approach may require standardization of Treg expansion methods and dosing. Inducible Tregs (iTregs) can be seamlessly generated, but controversial pre-clinical findings and phenotype instability have hampered their translation into the clinic. Here, we review the current biological differences between nTregs and iTregs, as well as their effects on GVHD and graft-versus-leukemia (GVL) responses. We conclude by exploring the idea of combinational cellular therapies for the prevention of GVHD and preservation of GVL.

Citing Articles

TCF-1 negatively regulates the suppressive ability of canonical and noncanonical Tregs.

Mammadli M, Suo L, Sen J, Karimi M J Leukoc Biol. 2023; 113(5):489-503.

PMID: 36806938 PMC: 11651127. DOI: 10.1093/jleuko/qiad019.

Dendritic cell-derived IL-27 p28 regulates T cell program in pathogenicity and alleviates acute graft-versus-host disease.

Gong H, Ma S, Chen J, Yang B, Liu S, Liu X Signal Transduct Target Ther. 2022; 7(1):319.

PMID: 36109504 PMC: 9477797. DOI: 10.1038/s41392-022-01147-z.

TNFR2 blockade of regulatory T cells unleashes an antitumor immune response after hematopoietic stem-cell transplantation.

Moatti A, Debesset A, Pilon C, Beldi-Ferchiou A, Leclerc M, Redjoul R J Immunother Cancer. 2022; 10(4).

PMID: 35387779 PMC: 8987798. DOI: 10.1136/jitc-2021-003508.

MicroRNA-31 regulates T-cell metabolism via HIF1α and promotes chronic GVHD pathogenesis in mice.

Wu Y, Mealer C, Schutt S, Wilson C, Bastian D, Sofi M Blood Adv. 2022; 6(10):3036-3052.

PMID: 35073581 PMC: 9131913. DOI: 10.1182/bloodadvances.2021005103.

Interleukin-2-inducible T-cell kinase (Itk) signaling regulates potent noncanonical regulatory T cells.

Mammadli M, Harris R, Suo L, May A, Gentile T, Waickman A Clin Transl Med. 2021; 11(12):e625.

PMID: 34919342 PMC: 8679839. DOI: 10.1002/ctm2.625.

References

Guillonneau C, Picarda E, Anegon I . CD8+ regulatory T cells in solid organ transplantation. Curr Opin Organ Transplant. 2010; 15(6):751-6. DOI: 10.1097/MOT.0b013e32834016d1. View

Zhao C, Shi G, Vistica B, Hinshaw S, Wandu W, Tan C . Induced regulatory T-cells (iTregs) generated by activation with anti-CD3/CD28 antibodies differ from those generated by the physiological-like activation with antigen/APC. Cell Immunol. 2014; 290(2):179-84. DOI: 10.1016/j.cellimm.2014.06.004. View

Cao X, Cai S, Fehniger T, Song J, Collins L, Piwnica-Worms D . Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity. 2007; 27(4):635-46. DOI: 10.1016/j.immuni.2007.08.014. View

GERSHON R, Kondo K . Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology. 1970; 18(5):723-37. PMC: 1455602. View

Ohkura N, Hamaguchi M, Morikawa H, Sugimura K, Tanaka A, Ito Y . T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development. Immunity. 2012; 37(5):785-99. DOI: 10.1016/j.immuni.2012.09.010. View

Hippen K, Merkel S, Schirm D, Sieben C, Sumstad D, Kadidlo D . Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity. Sci Transl Med. 2011; 3(83):83ra41. PMC: 3551476. DOI: 10.1126/scitranslmed.3001809. View

Lio C, Hsieh C . Becoming self-aware: the thymic education of regulatory T cells. Curr Opin Immunol. 2010; 23(2):213-9. PMC: 3061250. DOI: 10.1016/j.coi.2010.11.010. View

Sarris M, Andersen K, Randow F, Mayr L, Betz A . Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition. Immunity. 2008; 28(3):402-13. PMC: 2726439. DOI: 10.1016/j.immuni.2008.01.012. View

Chen W, Jin W, Hardegen N, Lei K, Li L, Marinos N . Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med. 2003; 198(12):1875-86. PMC: 2194145. DOI: 10.1084/jem.20030152. View

10.

Yang X, Jiang K, Hirahara K, Vahedi G, Afzali B, Sciume G . EZH2 is crucial for both differentiation of regulatory T cells and T effector cell expansion. Sci Rep. 2015; 5:10643. PMC: 4473539. DOI: 10.1038/srep10643. View

11.

Sawant D, Vignali D . Once a Treg, always a Treg?. Immunol Rev. 2014; 259(1):173-91. PMC: 4008876. DOI: 10.1111/imr.12173. View

12.

Levings M, Sangregorio R, Roncarolo M . Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med. 2001; 193(11):1295-302. PMC: 2193376. DOI: 10.1084/jem.193.11.1295. View

13.

Fontenot J, Gavin M, Rudensky A . Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003; 4(4):330-6. DOI: 10.1038/ni904. View

14.

Schmidt A, Oberle N, Krammer P . Molecular mechanisms of treg-mediated T cell suppression. Front Immunol. 2012; 3:51. PMC: 3341960. DOI: 10.3389/fimmu.2012.00051. View

15.

Solomon B, Mueller C, Chae W, Alabanza L, Bynoe M . Neuropilin-1 attenuates autoreactivity in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 2011; 108(5):2040-5. PMC: 3033275. DOI: 10.1073/pnas.1008721108. View

16.

Morawski P, Mehra P, Chen C, Bhatti T, Wells A . Foxp3 protein stability is regulated by cyclin-dependent kinase 2. J Biol Chem. 2013; 288(34):24494-502. PMC: 3750148. DOI: 10.1074/jbc.M113.467704. View

17.

Cortesini R, LeMaoult J, Ciubotariu R, Cortesini N . CD8+CD28- T suppressor cells and the induction of antigen-specific, antigen-presenting cell-mediated suppression of Th reactivity. Immunol Rev. 2001; 182:201-6. DOI: 10.1034/j.1600-065x.2001.1820116.x. View

18.

Nishikawa H, Jager E, Ritter G, Old L, Gnjatic S . CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients. Blood. 2005; 106(3):1008-11. DOI: 10.1182/blood-2005-02-0607. View

19.

Roychoudhuri R, Hirahara K, Mousavi K, Clever D, Klebanoff C, Bonelli M . BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis. Nature. 2013; 498(7455):506-10. PMC: 3710737. DOI: 10.1038/nature12199. View

20.

DuPage M, Chopra G, Quiros J, Rosenthal W, Morar M, Holohan D . The chromatin-modifying enzyme Ezh2 is critical for the maintenance of regulatory T cell identity after activation. Immunity. 2015; 42(2):227-238. PMC: 4347854. DOI: 10.1016/j.immuni.2015.01.007. View